These data support the possibility that STB-HO could be applied for NK cell-mediated immunotherapy against tumor by increasing the absolute number of NK cells, as the insufficient number of NK cells is one of the major impediments for efficient treatment44. This evidence concerns the gene HMOX1 and neoplasm.